These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29634143)

  • 1. [Afalaza in the management of patients with chronic pelvic pain syndrome].
    Neimark AI; Neimark BA; Nozdrachev NA; Kondrateva YS; Borisenko DV; Arkhipov DO; Makarova AA; Oberemok PA
    Urologiia; 2018 Mar; (1):106-111. PubMed ID: 29634143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological evidence of the ischemic nature of the prostatic fibrosis in the classical chronic pelvic pain syndrome / IIIB chronic prostatitis].
    Kogan MI; Matsionis AE; Belousov II; Povilaitite PE
    Urologiia; 2018 Jul; (3):12-19. PubMed ID: 30035413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modern view on etiology, pathogenesis and treatment of chronic pelvic pain syndrome].
    Vinarov AZ
    Urologiia; 2017 Apr; (1):114-122. PubMed ID: 28394534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic prostatitis/chronic pelvic pain syndrome: symptoms are aggravated by cold and become less distressing with age and time.
    Hedelin H; Jonsson K
    Scand J Urol Nephrol; 2007; 41(6):516-20. PubMed ID: 17853027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic prostatitis/chronic pelvic pain syndrome in adolescents compared with that in young adults.
    Lee KC; Cho IR
    Investig Clin Urol; 2017 Jul; 58(4):267-270. PubMed ID: 28681037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III.
    Cornel EB; van Haarst EP; Schaarsberg RW; Geels J
    Eur Urol; 2005 May; 47(5):607-11. PubMed ID: 15826751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
    Kaplan SA; Volpe MA; Te AE
    J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response.
    Shahed AR; Shoskes DA
    J Androl; 2000; 21(5):669-75. PubMed ID: 10975414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
    Choe HS; Lee SJ; Han CH; Shim BS; Cho YH
    J Infect Chemother; 2014 Jan; 20(1):20-5. PubMed ID: 24462419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.
    Polackwich AS; Shoskes DA
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):132-8. PubMed ID: 26951713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC; Downey J; Ardern D; Clark J; Nickel K
    J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats.
    Zhang K; Zeng X; Chen Y; Zhao R; Wang H; Wu J
    BMC Complement Altern Med; 2017 Jan; 17(1):75. PubMed ID: 28122556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
    Bates SM; Hill VA; Anderson JB; Chapple CR; Spence R; Ryan C; Talbot MD
    BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of alpha1-blockers in chronic prostatitis syndromes.
    Nickel JC
    BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate extract with aluminum hydroxide injection as a novel animal model for chronic prostatitis/chronic pelvic pain syndrome.
    Qi X; Han L; Liu X; Zhi J; Zhao B; Chen D; Yu F; Zhou X
    Urology; 2012 Dec; 80(6):1389.e9-15. PubMed ID: 23017785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study.
    Nickel JC; Forrest JB; Tomera K; Hernandez-Graulau J; Moon TD; Schaeffer AJ; Krieger JN; Zeitlin SI; Evans RJ; Lama DJ; Neal DE; Sant GR
    J Urol; 2005 Apr; 173(4):1252-5. PubMed ID: 15758763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
    Shoskes DA; Nickel JC; Kattan MW
    Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.